Psilocybin-Assisted Therapy for Veterans With PTSD
Open-label Phase 2 trial of psilocybin-assisted therapy in U.S. military veterans with PTSD. Underway now — closed to new enrollment; results pending.
This study is already underway and closed to new participants. It's listed here so you can see the research happening in the field right now.
This is an interventional study — the research team administers the treatment under a controlled, IRB-approved protocol. Participation never happens outside that protocol.
- Substance
- Psilocybin
- Status
- In progress
- Conditions
- PTSD
- Who can join
- U.S. military veterans (21–64) with PTSD
- Where
- Columbus, OH
- Run by
- Ohio State University (A. Davis)
- Registry ID
- NCT05554094 ↗
Enrollment status
This study is not currently recruiting new participants. Check the official registry record for its current status.
What taking part involves
Participants will receive two doses of psilocybin, approximately 2 weeks apart, in conjunction with preparatory and post-psilocybin therapy sessions
This study is not currently recruiting. Refer to the official registry record for updates.
Study data is sourced from ClinicalTrials.gov (U.S. National Library of Medicine) and verified university/nonprofit sources. This page is educational and is not medical advice or an endorsement. Details can change — always confirm on the official page above. ← Back to all studies